High serum B cell activating factor predicts good clinical response to rituximab in RA: pilot data. (9th March 2010) - Vital, E M; Cuthbert, R; Hensor, E; Parmar, R; Dass, S; Corscadden, D; Henshaw, K; Rawstron, A; Ponchel, F; Emery, P